Pro Dex (PDEX) Non Operating Investment Income (2013 - 2026)
Pro Dex (PDEX) reported Non Operating Investment Income of $2.4 million for Q1 2026, up 109.08% on a YoY basis from $1.1 million in Q1 2025, and up 1057.6% sequentially from -$250000.0 in Q4 2025.
Pro Dex (PDEX) Non Operating Investment Income (2013 - 2026) Analysis & Trends
Pro Dex (PDEX) has 10 years of Non Operating Investment Income data on file, last reported at $2.4 million in Q1 2026.
- For the quarter ending Q1 2026, Non Operating Investment Income rose 109.08% year-over-year to $2.4 million; the trailing twelve-month figure through Mar 2026 stood at $5.3 million (up 303.73% YoY), and the FY2025 full-year result was $1.5 million, up 136.87% from the prior year.
- Non Operating Investment Income grew to $2.4 million in Q1 2026, from -$250000.0 in the prior quarter.
- In the past five years, Non Operating Investment Income ranged from a high of $3.3 million in Q3 2025 to a low of -$2.6 million in Q3 2023.
- A 5-year average of $424294.1 and a median of $242000.0 in 2023 frame the typical range for Non Operating Investment Income.
- Across the five-year window, Non Operating Investment Income surged 3361.9% in 2022 and tumbled 700.71% in 2023, its largest moves.
- Tracing PDEX's Non Operating Investment Income over 5 years: stood at $2.7 million in 2022, then plunged by 101.46% to -$40000.0 in 2023, then soared by 292.5% to $77000.0 in 2024, then tumbled by 424.68% to -$250000.0 in 2025, then soared by 1057.6% to $2.4 million in 2026.
- Business Quant data shows PDEX's Non Operating Investment Income at $2.4 million in Q1 2026, -$250000.0 in Q4 2025, and $3.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn | - |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn | - |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn | - |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn | -10.13 Mn |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn | - |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn | - |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn | - |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | - |
| 10 | Pro Dex | 187.29 Mn | 178.23 Mn | 6.13 Mn | 2.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.39 Mn |
| Mar 31, 2026 | 2.39 Mn |
| Dec 31, 2025 | -250,000.00 |
| Dec 31, 2025 | -250,000.00 |
| Sep 30, 2025 | 3.30 Mn |
| Sep 30, 2025 | 3.30 Mn |
| Jun 30, 2025 | -134,000.00 |
| Jun 30, 2025 | -134,000.00 |
| Mar 31, 2025 | 1.15 Mn |
| Mar 31, 2025 | 1.15 Mn |
| Dec 31, 2024 | 77,000.00 |
| Dec 31, 2024 | 77,000.00 |
| Sep 30, 2024 | 433,000.00 |
| Sep 30, 2024 | 433,000.00 |
| Jun 30, 2024 | -340,000.00 |
| Jun 30, 2024 | -340,000.00 |
| Mar 31, 2024 | -1.19 Mn |
| Mar 31, 2024 | -1.19 Mn |
| Dec 31, 2023 | -40,000.00 |
| Dec 31, 2023 | -40,000.00 |